This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Should You Hold Community Health in Your Portfolio?
by Zacks Equity Research
Banking on divestitures and buyouts along with restructuring plans, Community Health (CYH) holds potential to reap benefits for investors.
5 Factors That Make Acadia Healthcare Stock Look Unattractive
by Zacks Equity Research
Rising expenses, underperforming U.K business and low guidance are a drag on Acadia Healthcare's (ACHC) stock.
Why Is Community Health Systems (CYH) Up 14.6% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Avoid Acadia Healthcare Stock Now
by Zacks Equity Research
Lack of clarity on the sale of its underperforming U.K. business continues to hurt Acadia Healthcare (ACHC).
Community Health's (CYH) Q2 Loss Widens, Revenues Fall Y/Y
by Zacks Equity Research
Community Health's (CYH) second-quarter results suffer due to lower admissions.
Community Health Systems (CYH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 9.62% and 3.06%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Community Health Systems (CYH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Community Health Systems (CYH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare Up 30% in a Year: Will the Rally Sustain?
by Zacks Equity Research
HCA Healthcare (HCA) stock rallies on the back of increase in admissions. Also, acquisitions made by the company are driving business growth.
Community Health to Sell Hospital to Focus on Core Businesses
by Zacks Equity Research
Community Health (CYH) will divest its Bluefield Regional Medical Center to concentrate on its core operations.
Why Should You Hold Community Health in Your Portfolio?
by Zacks Equity Research
Riding high on its restructuring initiative and growth strategy, Community Health (CYH) holds immense potential to reap benefits for investors.
Options Traders Expect Huge Moves in Community Health (CYH) Stock
by Zacks Equity Research
Investors need to pay close attention to Community Health (CYH) stock based on the movements in the options market lately.
Community Health Systems (CYH) Down 15.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health (CYH) Incurs Wider-Than-Expected Loss in Q1
by Zacks Equity Research
Community Health's (CYH) first-quarter earnings suffer due to lower admissions.
Is a Beat Likely for Universal Health (UHS) Q1 Earnings?
by Zacks Equity Research
Universal Health's (UHS) Q1 is likely to gain traction from higher admissions as well as licensed beds. However, the same might be partially offset by escalating costs.
Community Health Systems (CYH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Community Health Systems (CYH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene's (CNC) Q1 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Centene's (CNC) first-quarter earnings top on solid revenue growth.
Community Health to Sell Unit for Streamlining Operations
by Zacks Equity Research
Community Health (CYH) to divest 245-bed Tennova Healthcare - Lebanon in Tennessee to focus on its profitable businesses.
Why Is Community Health Systems (CYH) Up 2.2% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HCA Healthcare's Organic & Inorganic Strategies Drive Growth
by Zacks Equity Research
A number of acquisitions, network expansion, technological investment and strong balance sheet drive growth at HCA Healthcare (HCA).
Community Health (CYH) Q4 Loss Wider Than Expected, Down Y/Y
by Zacks Equity Research
Community Health's (CYH) Q4 results disappoint with loss from decline in admissions, partially offset by lower expenses.
Community Health Systems (CYH) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 27.59% and 1.94%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Community Health Systems (CYH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Which Stock to Emulate HCA Healthcare (HCA) Success in 2019?
by Zacks Equity Research
While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.
Hospital Industry Outlook: High Cost, Shift of Care Pose Concerns
by Zacks Equity Research
The hospital industry should grow on increased demand from an aging population, rising incidence of disease and technological innovation amid shortage of labor and shift of care to a low-cost setting.